Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment

Clinical trial NCT05171972 · COMPLETED

Trial details

NCT number: NCT05171972
Sponsor: University of Southern California
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2022-01-29
Primary completion: 2025-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.